PEAK6 Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

PEAK6 Investments’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-75,500	Closed	-$3.47M	–	6082
2022 Q1	$3.47M	Sell	75,500 -81,400	-52%	-$3.88M	0.01%	1372
2021 Q4	$9.61M	Sell	156,900 -416,000	-73%	-$28.8M	0.02%	734
2021 Q3	$42.8M	Sell	572,900 -1,876,700	-77%	-$157M	0.1%	180
2021 Q2	$227M	Sell	2,449,600 -1,439,600	-37%	-$122M	0.54%	25
2021 Q1	$345M	Buy	3,889,200 +3,727,700	+2,308%	+$370M	0.84%	12
2020 Q4	$15.1M	Buy	+161,500	New	+$12.9M	0.03%	498

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

PEAK6 Investments's ARKG Position: Q2 2022 in Review

PEAK6 Investments sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 63,403 shares — an estimated $2.91M sold.

PEAK6 Investments first reported a position in ARKG in Q4 2020 and held it in 5 quarters. The position peaked at $18.7M in Q1 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

PEAK6 Investments reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
PEAK6 Investments sold 63,403 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $2.91M.
PEAK6 Investments first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 5 quarters.
PEAK6 Investments's ARK Genomic Revolution ETF position peaked at $18.7M in Q1 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.